| Organism name | Vancouveria hexandra |
|---|---|
| Genus | Vancouveria |
| Family | Berberidaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Vancouveria hexandra |
|---|---|
| Linked NCBI taxonomy ID | 46959 |
| Linked level | species |
| Family in NCBI taxonomy | Berberidaceae |
|---|---|
| ID | 41773 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | eudicotyledons |
|---|---|
| ID | 71240 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00005807
|
Ikarisoside F
|
No. 1 | No. 15 |
|
||||
|
C00005810
|
Hexandraside E
/ 8-Prenylkaempferol 3,7-diglucoside / Noranhydroicaritin 3,7-diglucoside / 3,4',5,7-Tetrahydroxy-8-(3-methyl-2-butenyl)flavone 3,7-diglucoside / 3,7-Bis(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
No. 1 | No. 15 |
|
||||
|
C00005811
|
Epimedoside A
|
C092397
|
No. 1 | No. 15 |
|
|||
|
C00005824
|
Icariin
|
CHEMBL553204
CHEMBL1515685 CHEMBL2308655 |
C056599
|
6 / 1 / 1 | 6 / 9 | No. 1 | No. 15 |
|
|
C00005823
|
Anhydroicaritin 3,7-diglucoside
|
No. 1 | No. 15 |
|
||||
|
C00005816
|
Hexandraside C
|
C072227
|
No. 5 | No. 15 |
|
|||
|
C00005814
|
Ikarisoside C
|
C470266
|
No. 5 | No. 15 |
|
|||
|
C00005813
|
Epimedoside E
|
No. 5 | No. 15 |
|
||||
|
C00006059
|
Anhydroicaritin 3-(6'''-acetylgalactosyl)(1->3)-rhamnoside-7-glucoside
|
C064694
|
No. 5 | No. 15 |
|
|||
|
C00005827
|
Anhydroicaritin 3-galactosyl-(1->3)-rhamnoside-7-glucoside
|
C064693
|
No. 5 | No. 15 |
|
|||
|
C00005828
|
Epimedin A
|
No. 5 | No. 15 |
|
||||
|
C00005829
|
Epimedin A1
/ Hexandraside F |
No. 5 | No. 15 |
|
||||
|
C00005831
|
Hexandraside D
|
C072228
|
No. 5 | No. 15 |
|
|||
|
C00005826
|
Epimedin B
|
C106053
|
No. 5 | No. 15 |
|
|||
|
C00013408
|
5,7-Dihydroxy-2-[4-hydroxy-3-(2-hydroxy-3-methyl-3-butenyl)phenyl]-6-(2-hydroxy-3-methyl-3-butenyl)-4H-1-benzopyran-4-one
|
No. 14 | No. 15 |
|
||||
|
C00013431
|
Yinyanghuo C
/ 2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)-5,7-dihydroxy-4H-1-benzopyran-4-one |
No. 24 | No. 15 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P06746 | DNA polymerase beta | Enzyme | C00005824 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00005824 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00005824 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005824 | 0 / 0 |
| P51160 | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | PDE_6C | C00005824 | 1 / 1 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005824 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 650 | BMP2, BDA2, BMP2A | bone morphogenetic protein 2 |
C00005824
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00005824
|
| 8654 | PDE5A, CGB-PDE, CN5A, PDE5 | phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
C00005824
|
| 5241 | PGR, NR3C3, PR | progesterone receptor |
C00005824
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005824
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00005824
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000544 | Alzheimer Disease |
C00005824
|
| D001284 | Atrophy |
C00005824
|
| D001847 | Bone Diseases |
C00005824
|
| D002545 | Brain Ischemia |
C00005824
|
| D004487 | Edema |
C00005824
|
| D007172 | Erectile Dysfunction |
C00005824
|
| D007859 | Learning Disorders |
C00005824
|
| D008569 | Memory Disorders |
C00005824
|
| D010024 | Osteoporosis |
C00005824
|